Frost Radar™: Digital Biomarkers, 2023
Published on: 19-Oct-2023 | SKU: HC_2023_270

Need more details?
$4,950.00
DownloadLink
Need more details?

Digital biomarkers play a crucial role in early disease detection and prevention; data-driven insights generated by wearable support early diagnosis, real-time monitoring of patient health, precise healthcare delivery, remote patient monitoring, and advanced R&D effort in the treatment of neurodegenerative conditions. While innovation focuses on the development of contactless devices, vocal digital biomarkers, the use of AI, pharmaceutical companies are collaborating with digital health start-ups to speed up clinical trials, develop new products faster, and improve patient engagement and outcomes.

The Frost Radar™ aligns with the essence of the healthcare digital revolution, and it provides a gateway to a future approach where health management is patient-centric, proactive, and precise, enabled by digital biomarkers. The research study offers intelligence so that industry stakeholders can be at the forefront of that revolution.

Strategic Imperative

Traditional and Emerging Digital Biomarkers

Digital Biomarker Applications

Growth Environment

Growth Environment (continued)

Frost Radar™: Digital Biomarkers

Competitive Environment

Competitive Environment (continued)

Verily Life Sciences

Huma Therapeutics

Biofourmis

Evidation Health

Koneksa Health

Empatica

Medidata Solutions

Sonde Health

Ellipsis Health

Altoida

Canary Speech

Kintsugi Mindful Wellness

Innodem Neuroscience

EVOCAL Health

Lapsi Health

Strategic Insights

Significance of Being on the Frost Radar™

Frost Radar™ Empowers the CEO’s Growth Team

Frost Radar™ Empowers Investors

Frost Radar™ Empowers Customers

Frost Radar™ Empowers the Board of Directors

Frost Radar™: Benchmarking Future Growth Potential

Frost Radar™: Benchmarking Future Growth Potential

Legal Disclaimer

Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform

Growth Index

Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.

  • Market Share (previous 3 years)
    This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years.
  • Revenue Growth (previous 3 years)
    This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™.
  • Growth Pipeline
    This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities.
  • Vision and Strategy
    This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision?
  • Sales and Marketing
    This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.

Innovation Index

Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.

  • INNOVATION SCALABILITY
    This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals.
  • RESEARCH AND DEVELOPMENT
    This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline.
  • PRODUCT PORTFOLIO
    This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue.
  • MEGATRENDS LEVERAGE
    This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline.
  • CUSTOMER ALIGNMENT
    This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.

Significance of Being on the Frost Radar™

Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.

  • GROWTH POTENTIAL
    Your organization has significant future growth potential, which makes it a Company to Action.
  • BEST PRACTICES
    Your organization is well positioned to shape Growth Pipeline™ best practices in your industry.
  • COMPETITIVE INTENSITY
    Your organization is one of the key drivers of competitive intensity in the growth environment.
  • CUSTOMER VALUE
    Your organization has demonstrated the ability to significantly enhance its customer value proposition.
  • PARTNER POTENTIAL
    Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Digital biomarkers play a crucial role in early disease detection and prevention; data-driven insights generated by wearable support early diagnosis, real-time monitoring of patient health, precise healthcare delivery, remote patient monitoring, and advanced R&D effort in the treatment of neurodegenerative conditions. While innovation focuses on the development of contactless devices, vocal digital biomarkers, the use of AI, pharmaceutical companies are collaborating with digital health start-ups to speed up clinical trials, develop new products faster, and improve patient engagement and outcomes. The Frost Radar aligns with the essence of the healthcare digital revolution, and it provides a gateway to a future approach where health management is patient-centric, proactive, and precise, enabled by digital biomarkers. The research study offers intelligence so that industry stakeholders can be at the forefront of that revolution.
More Information
Deliverable Type Frost Radar
Author Ashish Kaul
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Digital Biomarker Trends
Keyword 2 Healthcare Technology Reports
Keyword 3 Biomarker Insights
Podcast No
WIP Number DACD-01-00-00-00

Frost Radar™: Digital Biomarkers, 2023

HealthcareFrost Radar™: Digital Biomarkers, 2023

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

RELEASE DATE
19-Oct-2023
REGION
Global
Deliverable Type
Frost Radar
Research Code: DACD-01-00-00-00
SKU: HC_2023_270
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC_2023_270